Filing Details

Accession Number:
0001144204-19-036669
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-30 16:30:23
Reporting Period:
2019-07-26
Accepted Time:
2019-07-30 16:30:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484565 Soleno Therapeutics Inc SLNO () NY
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
926475 N Larry Feinberg 262 Harbor Drive, 3Rd Fl
Stamford CT 06902
No No Yes No
941901 Oracle Partners Lp 262 Harbor Drive, 3Rd Fl
Stamford CT 06902
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share ("Common Stock") Acquisiton 2019-07-26 49,569 $2.14 2,665,050 No 4 P Indirect See footnote
Common Stock Acquisiton 2019-07-26 7,500 $2.14 350,334 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 855,243 Indirect See footnote
Footnotes
  1. These securities are owned by Oracle Partners, LP. ("Partners").
  2. These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners")
  3. These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
  4. Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
  5. Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.